Immunoglobulin levels in panic disorder patients

Pakistan Journal of Pharmaceutical Sciences

Volumn 25, Issue 1, 2012, Pages 149-153

  Nahar, Zabun ^a   Khanum, Sayema ^a   Harun, Saima ^a   Islam, Sheikh Nazrul ^a   Sobhan, Md Abdus ^b   Islam, Md Saiful ^a   Hasnat, Abul ^a  

^a UNIVERSITY OF DHAKA   (Bangladesh)

^b BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

Author keywords

Immunoglobulin; Panic disorder; Serum

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; AGE DISTRIBUTION; ARTICLE; BANGLADESH; BLOOD ANALYSIS; BODY MASS; CLINICAL ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATION; FEMALE; GENDER; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LOWEST INCOME GROUP; MALE; NORMAL HUMAN; NUTRITIONAL STATUS; PANIC; PREVALENCE; SOCIOECONOMICS; TURBIDIMETRY; UNIVERSITY HOSPITAL;

ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; PANIC DISORDER; SOCIOECONOMIC FACTORS;

EID: 84855397223     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorder, 4th edition (DSM-IV). American Psychiatric Association, Washington, D.C.
2. Baker A, Sadat AFMN, Hossain MI, Islam SKN and Hasnat A (2005). Immunoglobulin levels in manic patients. Dhaka Univ. J. Pharm. Sci., 4(2): 1816-1820.
3. Balatia C, Iscrulescu C and Sarbulescu A (1992). Serum immunoglobulin levels in schizophrenic disorders (manic and depressive). Rom. J. Neurol. Psychiatry., 30 (1): 63-71.
4. Bergquist MS, Rankin-Hill L, Sanchez-Ayendez M and Mendez Bryan R (1995). Across cultural comparison of adaptation to chronic pain among Anglo-American and native PuertoRican. Med. Anthropol., 16: 141.
5. Dati, F, Schumann G and Thomas L (1996). Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges from 14 patients in serum based on the standardization against the IFCC/ BCR/ CAP Reference Material (CRM 470). Eur. J. Clin. Chem. Clin. Biochem. 34: 517-520.
6. Delsi LE and Wyatt RJ (1984). Neurochemical aspects of schizophrenia. In: Handbook of Neurochemistry. Vol. 10 (ed. A. Lajtha) New York, Plenum.
7. Frasure A and Smith N (2000). Depresson and anxiety. Circulation. 101(16): 1919-1924.
8. st Edition. McGraw-Hill Companies, USA.
9. Hossain I, Sadat N, Hossain K, Qusar S, Islam, S.K. Islam, S and Hasnat, A (2007). Serum immunoglobulin profile in somatization disorder patients. German J Psychiatry. 10: 13-17.
10. Kaplan, HI and Sadock, BJ (1995). Comprehensive text book of psychiatry. Williams and Wilkins, Baltimore.
11. Karim P, Sadat AFMN, Hossain MI, Qusar MMAS, Islam SKN and Hasnat A (2005). Immunoglobulin (IgG, IgA, IgM) profiles in schizophrenic patients. Dhaka Univ. J. Pharm. Sci., 4(1): 39-44.
12. Langewitz W, Kiss A and Saner R (1995). Panic disorders in the emergency room. Ther Umsch., 52(3): 201-207.
13. Marazziti D, Ambrogi F, Vanacore R, Mignani V, Savino M and Palego L (1992). Immune cell imbalance in major depressive and panic disorder. Neuropsychobiology, 26(1-2): 23-26.
14. Mubarak A, Gad ES and Ibrahim WFAA (1999). Immunological study of manic patients. German J Psychiatry, 2: 48-60.
15. Nahar Z, Azad MAK, Rahman MA, Rahman MA, Bari W, Islam SN, Islam, MS and Hasnat, A. (2010). Comparative Analysis of Serum Manganese, Zinc, Calcium, Copper and Magnesium Level in Panic Disorder Patients. Biol. Trace Elem. Res., 133(3): 243-363.
16. Pesce AJ, and Kaplan LA (1987). Methods in clinical chemistry. The CV Mosby Company. St. louis M.O.
17. Pollack MH and Marzol PC (2000). Panic: course, complications and treatment of panic disorder. J. Psychopharmacol., 14(2 Suppl 1): S25- S30.
18. Ramesh C, Yeragani VK, Balan R and Pohl R (1991). A comparative study of immune status in panic disorder patients and controls. Aeta Psychiatr Scand., 84(4): 396-397.
19. Rayburn NR and Otto MW (2003). Cognitive behavioral therapy for panic disorder: A review of treatment elements, strategies and outcomes. CNS Spectr., 8(5): 356-362. (Pubitemid 36765018)
20. Sperner-Unterweger B (2005). Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications. Drugs, 65(11): 1493-520.
21. Taylor K (2000). Immuno-biochemical interactions in schizophrenia. Schizophr Res, 44(3): 245-246.
22. Teitz NW (1983). Clinical guide to laboratory tests, edited by q b Sanders Co., Philadelphia, p.483.
23. Tiwari SC, Lal N, Trivedi JK and Varma SL (1989). Relationship of immunoglobulin with the number and duration of schizophrenic episodes. Indian J Med Res. 90: 229-232. (Pubitemid 19193054)
24. Westenberg HG and Liebowitz MR (2000). Overview of panic and social anxiety disorders. J. Clin. Psychiatry, 65(14): 22-26.